← Leaderboards
John Mark Perry
University Of Kansas Medical Center
$992,378
Attributed
$2,977,133
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $815.1K · FY2022–25$1M$750K$500K$250K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$2,977,133 · 1
By mechanism
U01$2,977,133 · 1
Top collaborators
- Richard J Dipaolo6 shared
- Subhrajit Saha6 shared
Most similar at University Of Kansas Medical Center
Same institution · by research overlap
- Curtis Dean Klaassen$9,288,636
Others in their field
Other Rising Stars on “Play”
- Brian Todd Schaneberg · Illinois Institute Of Technology$13,469,813
- Judith Doherty$11,781,802
- Colin Osborne · University Of Texas Med Br Galveston$10,407,745
- Taleen Hanania · Psychogenics, Inc.$9,482,040
- Alexander Kolykhalov · Emory University$8,116,465
- Debra Burnin · Sri International$7,771,546
Research focus
PlayRadiation ToxicityMedical CountermeasureMyelogenousRadiationRadiation MitigationIrradiationLicensureMonocyteMouse ModelExposure ToInjuryRadiation ExposureRadiation InjuriesHourChemokineAnimal RuleGastrointestinalInflammatoryCellsInflammationBone MarrowChemokine ReceptorRecruit
Grant awards (6)
Modulation of chemokine signaling to mitigate radiation induced inflammation$670,308
U01 · FY2025 · AI
Modulation of chemokine signaling to mitigate radiation induced inflammation$671,909
U01 · FY2024 · AI
Modulation of chemokine signaling to mitigate radiation induced inflammation -suppl Collab$100,000
U01 · FY2024 · AI
Modulation of chemokine signaling to mitigate radiation induced inflammation$680,928
U01 · FY2023 · AI
Triterpenoids in mitigation of radiation induced acute or delayed inflammation$134,204
U01 · FY2023 · AI
Modulation of chemokine signaling to mitigate radiation induced inflammation$719,784
U01 · FY2022 · AI